B

BRT Blood Reprogramming Technologies Lda

1 employees

BRT develops direct cell reprogramming technologies to generate autologous blood products for regenerative medicine.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cancer Treatment
Research and Development
Direct Reprogramming
Hematopoietic Stem Cells
Medical
Health Care
Blood Reconstitution

Date founded

2017

FAQ